
Octapharma AG - Strategic SWOT Analysis Review
Description
Octapharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Octapharma AG (Octapharma) develops and manufactures human protein medicines. The company produces medicines derived from human plasma and human cell lines. Octapharma's major products focus on three therapeutic areas: haematology, immunotherapy, and critical care. It provides products for individuals with bleeding disorders, supports immune system functions, and helps restore haemostasis and blood volume in critically ill patients. The company sources plasma from company-owned plasma donation centers and other external sources. Octapharma owns plasma donation centers in the US and Germany and owns production facilities in Austria, Germany, France, Mexico, and Sweden. Its production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage, and distribution. Octapharma is headquartered in Lachen, Switzerland.
Octapharma AG Key Recent Developments
Aug 30,2025: BCC appoints Tim Snowball as director of communications
Jul 31,2025: University of Colorado Anschutz Medical Campus Awarded One of the Largest Clinical Trial Grants in Campus History to Lead Trauma Study
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Octapharma AG (Octapharma) develops and manufactures human protein medicines. The company produces medicines derived from human plasma and human cell lines. Octapharma's major products focus on three therapeutic areas: haematology, immunotherapy, and critical care. It provides products for individuals with bleeding disorders, supports immune system functions, and helps restore haemostasis and blood volume in critically ill patients. The company sources plasma from company-owned plasma donation centers and other external sources. Octapharma owns plasma donation centers in the US and Germany and owns production facilities in Austria, Germany, France, Mexico, and Sweden. Its production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage, and distribution. Octapharma is headquartered in Lachen, Switzerland.
Octapharma AG Key Recent Developments
Aug 30,2025: BCC appoints Tim Snowball as director of communications
Jul 31,2025: University of Colorado Anschutz Medical Campus Awarded One of the Largest Clinical Trial Grants in Campus History to Lead Trauma Study
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
31 Pages
- Section 1 - About the Company
- Octapharma AG - Key Facts
- Octapharma AG - Key Employees
- Octapharma AG - Major Products and Services
- Octapharma AG - History
- Octapharma AG - Company Statement
- Octapharma AG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Octapharma AG - Business Description
- R&D Overview
- Octapharma AG - Corporate Strategy
- Octapharma AG - SWOT Analysis
- SWOT Analysis - Overview
- Octapharma AG - Strengths
- Octapharma AG - Weaknesses
- Octapharma AG - Opportunities
- Octapharma AG - Threats
- Octapharma AG - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Octapharma AG, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Aug 30, 2025: BCC appoints Tim Snowball as director of communications
- Jul 31, 2025: University of Colorado Anschutz Medical Campus Awarded One of the Largest Clinical Trial Grants in Campus History to Lead Trauma Study
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Octapharma AG, Key Facts
- Octapharma AG, Key Employees
- Octapharma AG, Major Products and Services
- Octapharma AG, History
- Octapharma AG, Other Locations
- Octapharma AG, Subsidiaries
- Octapharma AG, Key Competitors
- Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Octapharma AG, Recent Deals Summary
- List of Figures
- Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.